USPTO Examiner TRINH HONG VAN N - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18810458RIGIDIZING OVERTUBE WITH HEMOSTASIS VALVEAugust 2024November 2024Allow300YesNo
18809322METHODS OF PERFORMING VASCULAR PROCEDURES USING A RIGIDIZING DEVICEAugust 2024December 2024Allow410NoNo
18590332DEVICES FOR INJECTING MEDICAMENTS AND METHODS OF USEFebruary 2024February 2025Allow1100YesNo
18471057NEEDLE WITH MULTI-BEVEL TIP GEOMETRYSeptember 2023March 2025Allow1811YesNo
18243330NEEDLE-BASED DEVICE WITH A SAFETY MECHANISM IMPLEMENTED THEREINSeptember 2023February 2025Allow1710YesNo
18460723DUAL CHAMBER SYRINGE AND METHODS OF USE THEREOFSeptember 2023August 2024Allow1100YesNo
18241462SYRINGE PLUNGER FINGER RING STRUCTURESSeptember 2023February 2025Allow1720YesNo
18223294NEEDLE-BASED DEVICE WITH EXTERNAL SAFETY CAP AND A NEEDLE GUIDE ELEMENT THEREOFJuly 2023September 2023Allow200YesNo
18221848NEEDLE-BASED DEVICE BASED ON DIRECT WING-BASED COUPLING OF A NEEDLE SHIELD TO A BARREL THEREOF AND SAFETY MECHANISM IMPLEMENTED THEREINJuly 2023February 2024Allow710NoNo
18209088Injection Device with Ergonomic Housing Form FactorJune 2023March 2025Abandon2110NoNo
18202987Septum for Access PortMay 2023June 2024Allow1300YesNo
18127710DELIVERY SYSTEM FOR DELIVERING A DRUG DEPOT TO A TARGET SITE UNDER IMAGE GUIDANCE AND METHODS AND USES OF SAMEMarch 2023June 2024Allow1400YesNo
18041964A SELF-RETAINING ENEMA NOZZLE AND AN ENEMA SYSTEM COMPRISING SAID ENEMA NOZZLEFebruary 2023November 2023Allow910YesNo
18097334NON-DISPOSABLE LIQUID DISPENSING DEVICEJanuary 2023February 2024Allow1311YesNo
18007850An Enema Nozzle and an Enema Device Comprising Said Enema NozzleDecember 2022January 2024Allow1411YesNo
17928941SYRINGE WITH CONTROLLABLE BREAKING FEATURESDecember 2022September 2023Allow901YesNo
17983540SYRINGE PLUNGER FINGER RING STRUCTURESNovember 2022June 2024Allow1910YesNo
17903879RIGIDIZING DEVICESSeptember 2022December 2022Allow300YesNo
17902770NESTED RIGIDIZING DEVICESSeptember 2022March 2023Allow701YesNo
17877305SYSTEMS AND METHODS FOR HEAD HEIGHT PRESSURE COMPENSATIONJuly 2022September 2023Allow1400YesNo
17874955Dual Chamber Syringe With Retractable NeedleJuly 2022March 2025Allow3220YesNo
17874629SYRINGE CONTROL STRUCTURE AND MANUFACTURE METHODJuly 2022May 2025Allow3440YesNo
17866930CATHETER INSERTION SYSTEMJuly 2022July 2024Allow2401YesNo
17867548SYSTEM AND METHOD FOR MONITORING AND CONTROLLING INTRAUTERINE PRESSURE USING A PRESSURE CUFFJuly 2022February 2025Allow3110NoNo
17865449Venous Access Port with Molded and/or Radiopaque IndiciaJuly 2022February 2024Allow1920YesNo
17845392DUAL-CHAMBER SYRINGE WITH DUAL-LUMEN INTRAVENOUS SETJune 2022March 2024Allow2021YesNo
17749909VISIBLE VALVE SYSTEM AND SPILL REDUCING SYSTEMMay 2022April 2025Abandon3411NoNo
17691682PACKAGING AND DEVICES FOR MIXING MEDICAMENT SUBSTANCESMarch 2022January 2025Abandon3421YesNo
17679244DISPOSABLE DELIVERY ASSEMBLY FOR A DRUG DELIVERY DEVICEFebruary 2022August 2024Allow3021YesNo
17666251Septum for Access PortFebruary 2022February 2023Allow1300YesNo
17622410SYRINGEDecember 2021March 2024Allow2720YesNo
17550779Syringe Plunger Loop for Improved Aspiration and InjectionDecember 2021May 2024Abandon2920YesNo
17526705Fertility Kits with Syringes and Collection Jars, and Method of UseNovember 2021September 2022Allow1020YesNo
17494904NEEDLE-BASED DEVICE WITH A SAFETY MECHANISM IMPLEMENTED THEREINOctober 2021June 2023Allow2010YesNo
17493785DYNAMICALLY RIGIDIZING COMPOSITE MEDICAL STRUCTURESOctober 2021June 2022Allow811YesNo
17484558NASAL ASPIRATOR WITH FINGER GRIPSSeptember 2021January 2024Abandon2810YesNo
17480862METHOD AND APPARATUS FOR IRRIGATIONSeptember 2021December 2023Allow2721YesNo
17404366MICRONEEDLE APPLICATOR AND MICRONEEDLE PATCH APPLICATION DEVICEAugust 2021December 2023Abandon2810NoNo
17393763INFUSION PROTECTION AND SECURING MECHANISMAugust 2021July 2024Abandon3510NoNo
17382508SYRINGE DEVICE WITH A DOSE LIMITING MECHANISM AND AN ADDITIONAL SAFETY MECHANISMJuly 2021December 2024Allow4010YesNo
17423547Microarray ReceptacleJuly 2021January 2025Allow4220NoNo
17351006SYSTEM AND METHOD FOR MICRODOSE INJECTIONJune 2021August 2023Allow2600YesNo
17242776GUIDE APPARATUS FOR TANGENTIAL ENTRY INTO SUPRACHOROIDAL SPACEApril 2021April 2024Allow3621YesNo
17236854Method and Device for Intraoperative Determination of Drag Coefficient Values of Different Medical Instruments in the Use of a Medical Fluid PumpApril 2021May 2023Abandon2410NoNo
17234793NEEDLE-BASED DEVICE WITH A SAFETY MECHANISM IMPLEMENTED THEREINApril 2021September 2021Allow510NoNo
17228797SYRINGE PLUNGER FINGER RING STRUCTURESApril 2021July 2023Allow2730YesNo
17207245Ergonomic Fine-Precision Injection And Aspiration Safety Device For Aesthetic InjectionsMarch 2021May 2024Abandon3710NoNo
17193144SYRINGE WITH PLUNGER REACTION PRESSURE REDUCTION STRUCTUREMarch 2021April 2023Allow2610NoNo
17193167LUER-LOCK FASTENING NEEDLE HUBMarch 2021March 2024Allow3620YesNo
17176138lnsufflation Retention Device with BalloonFebruary 2021June 2024Allow4000YesNo
17171338METHOD FOR ANESTHETIZING THE LIPSFebruary 2021June 2023Allow2820YesNo
17162531MULTI-LUMEN SPIKEJanuary 2021August 2024Allow4320YesNo
17162320Injection Device with Cammed Ram AssemblyJanuary 2021August 2024Allow4340YesNo
17158322DRUG DELIVERY DEVICES AND METHODSJanuary 2021February 2024Allow3720YesNo
17152706DYNAMICALLY RIGIDIZING COMPOSITE MEDICAL STRUCTURESJanuary 2021August 2021Allow711YesNo
17151159TWO-COMPONENT SYRINGEJanuary 2021April 2021Allow310YesNo
17259223DEVICES AND METHODS FOR ULTRASONIC DELIVERY OF AN AGENT WITHIN AN ORAL CAVITYJanuary 2021July 2024Abandon4220NoNo
17137490SYRINGE PLUNGER FINGER RING STRUCTURESDecember 2020December 2021Abandon1130YesNo
17106875INFUSION SYSTEM, DEVICE, AND METHOD HAVING ADVANCED INFUSION FEATURESNovember 2020October 2023Allow3510YesNo
17065735DOSE CLIP ASSEMBLY FOR SYRINGEOctober 2020May 2023Allow3111YesNo
17062036DEVICES AND METHODS FOR MAKING THERAPEUTIC FLUIDSOctober 2020December 2023Allow3811YesNo
17060188OVERTUBEOctober 2020April 2025Abandon5421YesNo
17038967PARTICLE IMPLANTER CAPABLE OF RAPIDLY SWITCHING IMPLANT NEEDLESSeptember 2020June 2023Abandon3320NoNo
17033921DERMAL INJECTION GUIDE DEVICESeptember 2020January 2023Abandon2801NoNo
16980253DEVICES FOR INJECTING MEDICAMENTS AND METHODS OF USESeptember 2020September 2023Allow3700YesNo
17011713Medical Syringe with Retractable Needle and Modified Plunger Handle with Concave Pressure Application SurfaceSeptember 2020April 2024Allow4320YesYes
16999788SYRINGE CONTROL STRUCTURE AND MANUFACTURE METHODAugust 2020May 2022Allow2110YesNo
16994596DUAL CHAMBER SYRINGE AND METHODS OF USE THEREOFAugust 2020June 2023Allow3421YesNo
16989244Needle-Free Transdermal Injection DeviceAugust 2020January 2024Allow4111NoNo
16944207AMBULATORY INFUSION PUMPS AND RESERVOIR ASSEMBLIES FOR USE WITH SAMEJuly 2020February 2023Allow3010YesNo
16940672Injection Device with Ergonomic Housing Form FactorJuly 2020March 2023Allow3210YesNo
16955321INJECTOR USABLE WITH DIFFERENT DIMENSION CARTRIDGESJune 2020September 2023Allow3811YesNo
16954469AN ACTIVATOR FOR A MEDICAMENT DELIVERY DEVICEJune 2020February 2023Allow3210YesNo
15930813REMOVABLE PARTIAL ARM RESTRAINTMay 2020May 2023Abandon3610NoNo
15930698DELAY DEVICE FOR A MEDICAL ADMINISTRATION APPLIANCEMay 2020March 2023Abandon3401NoNo
15929464METHOD OF STABILIZING CATHETER TUBE USING STABILIZING DEVICEMay 2020February 2023Allow3310YesNo
16861472INJECTION DEVICE FOR SUBRETINAL DELIVERY OF THERAPEUTIC AGENTApril 2020July 2020Allow300YesNo
16760253Device for Deterring Abuse of DrugsApril 2020November 2023Abandon4311NoNo
16759739FLUID DELIVERY APPARATUSApril 2020December 2023Allow4321YesNo
16756488Device for extracting a fluid from an ampouleApril 2020January 2023Allow3320YesNo
16754835SYRINGE FOR ONE-HANDED INJECTION AND ASPIRATIONApril 2020August 2021Allow1611YesNo
16838705INTRANASAL DRUG DELIVERY DEVICE AND METHODApril 2020September 2024Abandon5431NoNo
16651582Injector Gasket Falling-Off Prevention MechanismMarch 2020May 2022Allow2510YesNo
16831824NEEDLE-BASED DEVICE WITH A SAFETY MECHANISM IMPLEMENTED THEREINMarch 2020July 2021Allow1521YesNo
16645910PATCH INJECTORMarch 2020September 2020Allow710YesNo
16803310FLOW RATE MEASUREMENT AND CONTROL OF INFUSION DEVICESFebruary 2020November 2022Allow3301YesNo
16789274SYSTEMS, APPARATUSES AND METHODS FOR FLUID INFUSION INTO A BODYFebruary 2020August 2022Allow3011YesNo
16786781METHOD OF RESHAPING A BODY PARTFebruary 2020September 2022Abandon3210NoNo
16783794METHODS AND SYSTEMS ASSOCIATED A MEDICAL SLEEVE FOR INTRAVENOUS THERAPY LINESFebruary 2020May 2021Abandon1520NoNo
16778940Dual Chamber Syringe With Retractable NeedleJanuary 2020June 2022Allow2811YesNo
16631599DUAL-COMPARTMENT VITREOUS BODY INJECTORJanuary 2020November 2022Abandon3410NoNo
16743790RELEASEABLE CATHETER HUB RETAINERJanuary 2020September 2024Allow5660YesNo
16339771METHOD AND DEVICE FOR INTRAOPERATIVE DETERMINATION OF DRAG COEFFICIENT VALUES OF DIFFERENT MEDICAL INSTRUMENTS IN THE USE OF A MEDICAL FLUID PUMPDecember 2019March 2023Allow4720YesNo
16626373ACTUATOR AND DEVICE FOR SYNCHRONIZED INJECTION AND ASPIRATIONDecember 2019December 2021Allow2300YesNo
16712042SYRINGE WITH A LUER LOCK CONNECTORDecember 2019December 2024Abandon6040YesYes
16708649Septum for Access PortDecember 2019September 2021Allow2110YesNo
16683758MIX AND TRIGGERING ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICENovember 2019February 2022Allow2700YesNo
16676621MEDICAL PORT LOCATORNovember 2019October 2022Abandon3510NoNo
16671922DRIVE MECHANISM FOR A MEDICATION DELIVERY DEVICE AND MEDICATION DELIVERY DEVICENovember 2019September 2022Allow3510YesNo
16599548SYRINGE BODYOctober 2019February 2025Allow6050YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TRINH, HONG-VAN N.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
4
(80.0%)
Examiner Reversed
1
(20.0%)
Reversal Percentile
32.8%
Lower than average

What This Means

With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
6
(40.0%)
Not Allowed After Appeal Filing
9
(60.0%)
Filing Benefit Percentile
64.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner TRINH, HONG-VAN N - Prosecution Strategy Guide

Executive Summary

Examiner TRINH, HONG-VAN N works in Art Unit 3783 and has examined 252 patent applications in our dataset. With an allowance rate of 64.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner TRINH, HONG-VAN N's allowance rate of 64.3% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by TRINH, HONG-VAN N receive 2.47 office actions before reaching final disposition. This places the examiner in the 84% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by TRINH, HONG-VAN N is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +66.7% benefit to allowance rate for applications examined by TRINH, HONG-VAN N. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.4% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.8% of cases where such amendments are filed. This entry rate is in the 15% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 82% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 23.0% are granted (fully or in part). This grant rate is in the 14% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.2% of allowed cases (in the 59% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.